PDE5 inhibitor promotes melanin synthesis through the PKG pathway in B16 melanoma cells

Protein interaction network topology uncovers melanogenesis regulatory network components within functional genomics datasets

(2010) Hsiang Ho et al.   BMC Systems Biology

Targeting CREB for Cancer Therapy: Friend or Foe

(2010) X. Xiao et al.   CURRENT CANCER DRUG TARGETS

Sphingosylphosphorylcholine inhibits melanin synthesis via pertussis toxin-sensitive MITF degradation

(2010) Dong-Seok Kim et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

CREB's control of intrinsic and synaptic plasticity: implications for CREB-dependent memory models

(2010) Eva Benito et al.   TRENDS IN NEUROSCIENCES

Inhibitory Effect of 2,4,2′,4′-Tetrahydroxy-3-(3-methyl-2-butenyl)-chalcone on Tyrosinase Activity and Melanin Biosynthesis

(2009) Xiaodong Zhang et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Cellular mechanisms regulating human melanogenesis

(2009) H. Y. Park et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

A review of genetic disorders of hypopigmentation: lessons learned from the biology of melanocytes

(2009) Clio Dessinioti et al.   EXPERIMENTAL DERMATOLOGY

Dichloromethane fraction ofCimicifuga heracleifoliadecreases the level of melanin synthesis by activating the ERK or AKT signaling pathway in B16F10 cells

(2008) Ji Yeon Jang et al.   EXPERIMENTAL DERMATOLOGY

A potent tyrosinase activator from Radix Polygoni multiflori and its melanogenesis stimulatory effect in B16 melanoma cells

(2008) Shuyu Guan et al.   PHYTOTHERAPY RESEARCH